menu
    • menu

    Company profile for PharmaEssentia

    NEW Drugs in Dev: 6
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to our stakeholders. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading ...
    PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human diseases while aiming to bring long lasting value to our stakeholders. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life. PharmaEssentia was founded in 2003 by a group of Taiwanese-American executives and high-ranking scientists from leading biotechnology and pharmaceutical companies in the US, with a goal to develop treatments for myeloproliferative neoplasms, hepatitis and other diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmaEssentiaTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    13F, No. 3, YuanQu Sreet, NanKang District, Taipei 115, Taiwan (Nangang Softwa...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hq.pharmaessentia.com/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arab Health

    Arab Health

    Not Confirmed

    envelop Contact Supplier

    Arab Health

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaEssentia’s BESREMi Added to Guidelines for Thrombocythemia
    PharmaEssentia’s BESREMi Added to Guidelines for Thrombocythemia

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127377586/en/PharmaEssentia-Announces-Updated-NCCN-Clinical-Practice-Guidelines-Include-ropeginterferon-alfa-2b-njft-BESREMi-for-Treatment-of-Essential-Thrombocythemia-ET

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    FDA Sets August 30, 2026 PDUFA Goal Date For Ropeginterferon
    FDA Sets August 30, 2026 PDUFA Goal Date For Ropeginterferon

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/fda-confirms-a-pdufa-goal-date-of-august-30-2026-for-the-sbla-submission-of-ropeginterferon-alfa-2b

    PHARMIWEB
    13 Jan 2026
    Share Share
    PharmaEssentia Reports Positive Phase 2b ET Study Data
    PharmaEssentia Reports Positive Phase 2b ET Study Data

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/pharmaessentia-announces-positive-topline-phase-2b-data-from-exceed-et-study-evaluating-ropeginterfe

    PHARMIWEB
    12 Jan 2026
    Share Share
    PharmaEssentia USA Names Williams as Independent Director
    PharmaEssentia USA Names Williams as Independent Director

    24 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251224903318/en/PharmaEssentia-USA-Announces-Appointment-of-Jeffrey-Williams-as-Independent-Director

    BUSINESSWIRE
    24 Dec 2025
    Share Share
    PharmaEssentia Outlines 2026 Priorities at JP Morgan Conference
    PharmaEssentia Outlines 2026 Priorities at JP Morgan Conference

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215883518/en/PharmaEssentia-Announces-Presentation-at-J.P.-Morgan-Healthcare-Conference-and-Strategic-Priorities-for-2026

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    PharmaEssentia's Phase 3 SURPASS-ET Trial Published in The Lancet
    PharmaEssentia's Phase 3 SURPASS-ET Trial Published in The Lancet

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124044530/en/PharmaEssentia-Announces-Publication-of-Phase-3-SURPASS-ET-Results-in-The-Lancet-Haematology

    BUSINESSWIRE
    24 Nov 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact PharmaEssentia and get a quotation

    PharmaEssentia is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Gemcitabine bulk offered by PharmaEssentia

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search